However, the higher expression levels of ALG6 were associated with a better survival in colon adenocarcinoma (p = 0.028) and lung squamous cell carcinoma patients (p = 0.038), respectively (Figure S7c,e). Here, ALG6 is linked to squamous cell lung carcinoma.